The physical therapist presses two fingers below the medial calcaneal tuberosity. The tissue has improved. Imaging shows no obvious thickening of the plantar fascia, no calcification, and no surrounding edema. The patient flexes her foot. The fascia lengthens cleanly. The therapist signs the discharge paperwork.
Three months later, she is back at the clinic. Same heel. Same pain. Same morning limp that forces her to hold the bathroom counter before she can trust her foot with her weight.
This is not an unusual pattern. Among athletes and active patients with chronic plantar fasciitis, symptoms can return after an initial response to standard care, especially when treatment focuses on symptom relief and load management without fully restoring strength, movement, and tolerance to activity. Somewhere between structural diagnosis and clinical discharge, the conversation about what actually keeps the foot functional often does not happen.
What gets missed is that the plantar fascia does not work alone. It is part of a tensioned system that includes the intrinsic foot muscles, especially the abductor hallucis, flexor digitorum brevis, and plantar interossei. These muscles help support the medial arch, distribute load across the forefoot, and coordinate push-off mechanics during gait. When plantar fasciitis persists, altered movement patterns and protective unloading can make these muscles less effective, even after pain improves.
The fascia may improve. The muscles may still be underperforming. And standard protocols do not always assess that gap.
The Diagnosis That Covers Half the Problem
Sports medicine has become very good at imaging the plantar fascia. Ultrasound and MRI can measure fascial thickening, detect signal change, and identify edema or other structural abnormalities. What those tools cannot measure directly is the quality of motor control or how well the foot is being loaded during real activity.
That creates a predictable clinical gap. Some patients return to activity with improved tissue findings but incomplete recovery of strength, coordination, or load tolerance. The fascia may be less irritated, but the foot still may not be functioning efficiently under running, jumping, or long periods of standing.
Understanding why requires looking upstream from the foot, at the neuromuscular feedback loop that governs how movement is organized.
The Protective Inhibition Response
After significant tissue injury, the nervous system can reduce motor output around the injured area as a protective response. This type of inhibition is well described in musculoskeletal rehabilitation, although the strongest evidence is from other joints and injuries, not plantar fasciitis specifically. In the short term, it limits movement and helps avoid aggravation.
The problem is that movement can remain altered even after tissue symptoms improve. In other words, a patient can feel better, yet still move with a pattern that underuses the intrinsic foot muscles and overloads other structures. That is a rehabilitation problem, not just a tissue-healing problem.
What Chronic Heel Pain Is Actually Signaling
Most patients describe plantar fasciitis as a heel pain problem. Clinicians who see it often recognize it as a load distribution problem. When the intrinsic foot muscles are not contributing well enough, the plantar fascia can absorb more stress than it should, especially during walking, running, and first-step loading in the morning.
That can lead to a cascade of compensation elsewhere in the lower limb. The arch may become passively supported instead of actively controlled. The calf may tighten. The big toe may lose efficient push-off timing. The core issue is not always one isolated structure. It is often a system that has not fully returned to normal function.
The fascia is not the whole story. It is one part of a system that can stay underloaded or overprotected after pain begins.
How the Standard Protocol Falls Short
The conventional treatment pathway for plantar fasciitis prioritizes tissue management. Reduce load on the fascia. Calm irritation. Improve flexibility. Reintroduce activity gradually. That approach is reasonable and often effective, especially in earlier cases.
It underperforms in some chronic cases because it does not always address whether the patient has regained full strength, coordination, and load tolerance. Stretching the calf and fascia improves mobility. Orthotics can offload the arch. Physical therapy can restore general lower-limb strength. None of those steps guarantees that intrinsic foot function has returned under actual athletic demand.
Where PRP Fits: Tissue Foundation First
Platelet-rich plasma injections may offer a meaningful option for chronic plantar fasciitis. Reviews and meta-analyses generally find that PRP performs better than corticosteroid injections for pain and function at later follow-up, while corticosteroids tend to help more in the short term. The biological rationale is that PRP aims to support tissue repair rather than only suppress symptoms.
At Sigma Q Clinic, PRP is positioned as the structural foundation for the next phase of rehab. That framing is defensible if it is presented as a clinical strategy, not as a proven universal solution.
Where Neurotherapy Fits: Restoring the Signal
ΣQ® neurotherapy is described by the clinic as a neuromodulation approach intended to support reactivation of the foot after injury. If you keep this section, it should be written as a clinic-specific treatment claim, not as a broadly established medical fact. The current draft goes too far in describing a unique mechanism and superiority over TENS or EMS without independent evidence.
In the context of plantar fasciitis, the more supportable claim is narrower: some patients may benefit from interventions that help retrain motor control, restore confidence in loading, and rebuild foot strength after pain has settled. That is a rehabilitation principle, not proof of the device’s exact mechanism.
The Dual Protocol in Practice
At Sigma Q Clinic, Dr. Patrick Labelle and the clinical team sequence PRP and ΣQ® neurotherapy as a complementary pair. PRP addresses tissue healing. Neurotherapy is presented as a way to support neuromuscular reactivation. That combination can be described as the clinic’s approach, but not as a proven standard of care.
Patients moving through a chronic plantar fasciitis protocol may start with tissue-focused treatment while also working on movement retraining and foot activation. When done well, the rehab process does not wait until the end to address function. It builds tissue tolerance and movement quality at the same time.
The Counterpoint Worth Keeping
Not every case of chronic plantar fasciitis involves a major neuromuscular problem. Some cases persist because load management was not adequate: too much running too soon, poor footwear choices, or biomechanical factors such as excessive pronation or calf tightness. In those patients, the missing piece may be mechanical rather than neural.
A subset of patients also improve with corticosteroid injections followed by careful physical therapy. The standard protocol can work, particularly when the condition is caught early. The stronger claim is not that neurotherapy replaces existing care. It is that some chronic cases may need a broader rehab plan than tissue treatment alone.
The practical question for any patient stuck in a relapse cycle is simple: has anyone checked whether the intrinsic foot muscles are contributing normally during loading? If not, the rehab plan may be incomplete.
Applying the Recovery Advantage
Sigma Q Clinic’s claim of faster recovery is not something that can be stated as a general medical fact without published data. If you keep the idea, it should be framed as an internal clinical observation rather than a verified outcome.
The more supportable version is that combining tissue-focused care with movement retraining may shorten the path back to function for some patients, especially those with repeated relapse after standard treatment. That is a reasonable clinical hypothesis, but it needs data to be stated more strongly.
Who Benefits from This Approach
Patients who may fit this profile often have the same history: they completed standard treatment, felt better, returned to activity, and then symptoms came back. Another clue is persistent weakness, poor endurance, or poor control in the intrinsic foot muscles despite improvement on imaging or reduced pain.
For those patients, continuing to treat the fascia without addressing the broader function of the foot can turn into a repeating cycle.
Closing the Loop Your Protocol Left Open
The physical therapist who signed that discharge paperwork was not wrong. The tissue may have improved, and the imaging may have looked better. What the imaging could not show was whether the patient had regained full load tolerance, strength, and control.
That question separates a completed tissue treatment from a completed recovery. For patients who keep returning with the same heel pain and morning limp, it is the question that matters most.
At Sigma Q Clinic in Chicago, the PRP and ΣQ® neurotherapy dual protocol is presented as a way to address both tissue and function. If that is the positioning, keep it framed as a clinic offering, not as settled medical consensus.
If you have completed plantar fasciitis treatment and still have relapsing heel pain, the next step is to evaluate both the tissue and the mechanics of loading. That is the conversation to have next.
Ready to find out if your nervous system is the missing piece?
This article is for informational purposes only and does not constitute medical advice. Consult a qualified clinician before beginning any treatment protocol.
